Dr Janet Woodcock on the FDA’s new Breakthrough designation

In Orphan Drug Congress by Tim Peplow

Janet Woodcock, MD, Director of the FDA’s CDER drug division discusses the FDA’s new Breakthrough Designation for new drug approvals. Source: CurrentMedicine.TV